Literature DB >> 22721390

Heterocyclic chalcone analogues as potential anticancer agents.

Vikas Sharma1, Vipin Kumar, Pradeep Kumar.   

Abstract

Chalcones, aromatic ketones and enones acting as the precursor for flavonoids such as Quercetin, are known for their anticancer effects. Although, parent chalcones consist of two aromatic rings joined by a three-carbon α,β-unsaturated carbonyl system, various synthetic compounds possessing heterocyclic rings like pyrazole, indole etc. are well known and proved to be effective anticancer agents. In addition to their use as anticancer agents in cancer cell lines, heterocyclic analogues are reported to be effective even against resistant cell lines. In this connection, we hereby highlight the potential of various heterocyclic chalcone analogues as anticancer agents with a brief summary about therapeutic potential of chalcones, mechanism of anticancer action of various chalcone analogues, and current and future prospects related to the chalcones-derived anticancer research. Furthermore, some key points regarding chalcone analogues have been reviewed by analyzing their medicinal properties.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22721390

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  12 in total

Review 1.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

2.  Novel indolyl-chalcones target stathmin to induce cancer cell death.

Authors:  Barbara Wegiel; Yiqiang Wang; Mailin Li; Finith Jernigan; Lijun Sun
Journal:  Cell Cycle       Date:  2016-03-17       Impact factor: 4.534

3.  Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.

Authors:  Yiqiang Wang; Andreas Hedblom; Steffi K Koerner; Mailin Li; Finith E Jernigan; Barbara Wegiel; Lijun Sun
Journal:  Bioorg Med Chem Lett       Date:  2016-10-24       Impact factor: 2.823

4.  Some ferrocenyl chalcones as useful candidates for cancer treatment.

Authors:  Vašková Janka; Daniel Žatko; Vaško Ladislav; Perjési Pál; Poráčová Janka; Mojžišová Gabriela
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-28       Impact factor: 2.416

Review 5.  Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.

Authors:  Mamdouh F A Mohamed; Gamal El-Din A Abuo-Rahma
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

Review 6.  A mini review on pyridoacridines: Prospective lead compounds in medicinal chemistry.

Authors:  Vikas Sharma; Prabodh C Sharma; Vipin Kumar
Journal:  J Adv Res       Date:  2014-11-15       Impact factor: 10.479

7.  Synthetic chalcones with potent antioxidant ability on H₂O₂-induced apoptosis in PC12 cells.

Authors:  Jian-Zhang Wu; Chan-Chan Cheng; Lai-Lai Shen; Zhan-Kun Wang; Shou-Biao Wu; Wu-Lan Li; Su-Hua Chen; Rong-Ping Zhou; Pei-Hong Qiu
Journal:  Int J Mol Sci       Date:  2014-10-14       Impact factor: 5.923

8.  Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells.

Authors:  Romeo Romagnoli; Filippo Prencipe; Luisa Carlota Lopez-Cara; Paola Oliva; Stefania Baraldi; Pier Giovanni Baraldi; Francisco Estévez-Sarmiento; José Quintana; Francisco Estévez
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

9.  Design, synthesis and evaluation of novel 2,2-dimethyl-2,3-dihydroquinolin-4(1H)-one based chalcones as cytotoxic agents.

Authors:  Julie Jean; David S Farrell; Angela M Farrelly; Sinead Toomey; James W Barlow
Journal:  Heliyon       Date:  2018-09-04

10.  Antinociceptive Effect of 3-(2,3-Dimethoxyphenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one in Mice Models of Induced Nociception.

Authors:  Nur Izzati Ismail; Lee Ming-Tatt; Nordin Lajis; Muhammad Nadeem Akhtar; Ahmad Akira; Enoch Kumar Perimal; Daud Ahmad Israf; Mohd Roslan Sulaiman
Journal:  Molecules       Date:  2016-08-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.